-+ 0.00%
-+ 0.00%
-+ 0.00%

EU grants Merck Animal Health marketing authorization for Nobivac NXT HCPChFeLV cat vaccine

PUBT·07/31/2026 10:47:27
Listen to the news
EU grants Merck Animal Health marketing authorization for Nobivac NXT HCPChFeLV cat vaccine
  • European Commission granted marketing authorization for Merck Animal Health Ventures’ NOBIVAC NXT HCPChFeLV cat vaccine.
  • Product targets five feline infectious diseases, including FeLV, with one-week onset and up to three years of immunity.
  • Authorization follows a positive European Medicines Agency CVMP opinion issued on April 16, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck Animal Health Ventures published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein.